Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12622001434785
ACTRN12622001434785
Terminated
未知

Maintaining Remission of Ulcerative Colitis with Faecal Microbiota Transplantation: the MR-UC-FMT Trial

Central Adelaide Local Health Network0 sites36 target enrollmentNovember 8, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionslcerative ColitisInflammatory Bowel DiseaseUlcerative ColitisOral and Gastrointestinal - Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseases

Overview

Phase
未知
Intervention
Not specified
Conditions
lcerative Colitis
Sponsor
Central Adelaide Local Health Network
Enrollment
36
Status
Terminated
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 8, 2022
End Date
February 4, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Central Adelaide Local Health Network

Eligibility Criteria

Inclusion Criteria

  • •Patients aged 18 \- 75 years
  • •Formal diagnosis of UC for greater than or equal to 1 month
  • •Currently under the care of a gastroenterologist
  • •Mild to Moderately Active UC with Total Mayo score 3 to 10 inclusive.
  • •Mayo Endoscopic Sub Score greater than or equal to 2 (to ensure symptoms are due to UC and not due to a concurrent functional bowel disorder)

Exclusion Criteria

  • •Severe UC with Total Mayo score of greater than or equal to 11 or by Truelove Witts Criteria
  • •Diminished mental capacity preventing consent
  • •Surgical resection of any part of the intestine
  • •Anticoagulation or dual antiplatelet use
  • •Antibiotic use at time of enrolment
  • •Contraindications to the use of prednisolone (e.g. poorly controlled Diabetes Mellitus, history of steroid\-induced mental health complications such as depression, mania or psychosis)
  • •Plans for travel from South Australia for \>4 weeks during the 12 months study period

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Remission maintenance treatment of ulcerative colitis with tacrolimus in azathioprine-intolerant patients: a randomized comparative trial of 5-aminosalicylic acid (5-ASA) monotherapy versus 5-ASA and tacrolimus combination therapy.
JPRN-UMIN000003785Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine80
Recruiting
Not Applicable
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
NL-OMON54471Radboud Universitair Medisch Centrum40
Recruiting
Not Applicable
Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remissioulcerative colitis
JPRN-UMIN000043098Sapporo Medical University150
Completed
Not Applicable
Symptom improvement of ulcerative colitis after an induction dose of ustekinumab in Japanese clinical practice, measured using patient-reported outcomes
JPRN-UMIN000043753Janssen Pharmaceutical K.K136
Completed
Not Applicable
Histological remission in ulcerative colitis: comparing histological activity indexeslcerative colitisDigestive SystemUlcerative colitis
ISRCTN61139227Radboud University Medical Center (Netherlands)50